• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高危肺栓塞患者导管定向溶栓与导管定向取栓术的疗效:一项全国性分析。

Outcomes with catheter-directed thrombolysis vs. catheter-directed embolectomy among patients with high-risk pulmonary embolism: a nationwide analysis.

作者信息

Sedhom Ramy, Elbadawi Ayman, Megaly Michael, Athar Ahmed, Bharadwaj Aditya S, Prasad Vinoy, Cameron Scott J, Weinberg Ido, Mamas Mamas A, Messerli Adrian W, Jaber Wissam, Elgendy Islam Y

机构信息

Division of Cardiology, Loma Linda University Medical Center, 11234 Anderson St, Loma Linda, CA 92354, USA.

Division of Cardiology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390, USA.

出版信息

Eur Heart J Acute Cardiovasc Care. 2023 Apr 17;12(4):224-231. doi: 10.1093/ehjacc/zuad004.

DOI:10.1093/ehjacc/zuad004
PMID:36738291
Abstract

AIMS

To examine the shot-term outcomes with catheter-directed thrombolysis (CDT) vs. catheter-directed embolectomy (CDE) for high-risk pulmonary embolism (PE).

METHODS AND RESULTS

The Nationwide Readmissions Database was utilized to identify hospitalizations with high-risk PE undergoing CDE or CDT from 2016 to 2019. The main outcome was all-cause in-hospital mortality. Propensity score matching was used to compare the outcomes in both groups. Among 3216 high-risk PE hospitalizations undergoing catheter-directed interventions, 868 (27%) received CDE, 1864 (58%) received CDT, and 484 (15%) received both procedures. In the unadjusted analysis, the rate of all-cause in-hospital mortality was not different between CDE and CDT (39.6% vs. 34.2%, P = 0.07). After propensity score matching, there was no difference in the incidence of in-hospital mortality [adjusted odds ratio (aOR): 1.28, 95% confidence interval (CI): 0.95, 1.72, P = 0.10], intracranial haemorrhage (ICH) (adjusted OR 1.57, 95% CI: 0.75, 3.29, P = 0.23), or non-ICH bleeding (aOR: 1.17, 95% CI: 0.85, 1.62, P = 0.33). There were no differences in the length of stay, cost, and 30-day unplanned readmissions between both groups.

CONCLUSION

In this contemporary observational analysis of patients admitted with high-risk PE undergoing CDT or CDE, the rates of in-hospital mortality, ICH, and non-ICH bleeding events were not different.

摘要

目的

比较导管直接溶栓(CDT)与导管直接取栓术(CDE)治疗高危肺栓塞(PE)的短期疗效。

方法与结果

利用全国再入院数据库,确定2016年至2019年接受CDE或CDT治疗的高危PE住院患者。主要结局为全因院内死亡率。采用倾向评分匹配法比较两组的结局。在3216例接受导管介入治疗的高危PE住院患者中,868例(27%)接受了CDE,1864例(58%)接受了CDT,484例(15%)接受了两种治疗。在未调整分析中,CDE组和CDT组的全因院内死亡率无差异(39.6%对34.2%,P = 0.07)。倾向评分匹配后,院内死亡率(调整优势比[aOR]:1.28,95%置信区间[CI]:0.95,1.72,P = 0.10)、颅内出血(ICH)(调整OR 1.57,95% CI:0.75,3.29,P = 0.23)或非ICH出血(aOR:1.17,95% CI:0.85,1.62,P = 0.33)的发生率均无差异。两组在住院时间、费用和30天内非计划再入院方面也无差异。

结论

在这项对接受CDT或CDE治疗的高危PE患者的当代观察性分析中,院内死亡率、ICH和非ICH出血事件的发生率无差异。

相似文献

1
Outcomes with catheter-directed thrombolysis vs. catheter-directed embolectomy among patients with high-risk pulmonary embolism: a nationwide analysis.高危肺栓塞患者导管定向溶栓与导管定向取栓术的疗效:一项全国性分析。
Eur Heart J Acute Cardiovasc Care. 2023 Apr 17;12(4):224-231. doi: 10.1093/ehjacc/zuad004.
2
Short- and Long-Term Outcomes of Catheter-Directed Thrombolysis versus Pulmonary Artery Embolectomy in Pulmonary Embolism: A National Population-Based Study.导管直接溶栓与肺动脉血栓切除术治疗肺栓塞的短期和长期结局:一项全国基于人群的研究。
J Endovasc Ther. 2022 Jun;29(3):409-419. doi: 10.1177/15266028211054763. Epub 2021 Oct 27.
3
Utilization of catheter-directed thrombolysis in pulmonary embolism and outcome difference between systemic thrombolysis and catheter-directed thrombolysis.导管定向溶栓在肺栓塞中的应用以及全身溶栓与导管定向溶栓之间的疗效差异。
Catheter Cardiovasc Interv. 2015 Dec 1;86(7):1219-27. doi: 10.1002/ccd.26108. Epub 2015 Aug 26.
4
Unplanned 30-Day Readmissions after Management of Submassive and Massive Acute Pulmonary Embolism: Catheter-Directed versus Systemic Thrombolysis.亚大面积和大面积急性肺栓塞治疗后30天内的非计划再入院:导管定向溶栓与全身溶栓对比
J Vasc Interv Radiol. 2023 Jan;34(1):116-123.e14. doi: 10.1016/j.jvir.2022.09.017. Epub 2022 Sep 24.
5
Trends and outcomes of lytic-based therapies for high-risk pulmonary embolism: A nationwide analysis.基于溶栓的高危肺栓塞治疗的趋势与结局:一项全国性分析。
Vasc Med. 2024 Feb;29(1):26-35. doi: 10.1177/1358863X231211331. Epub 2023 Dec 12.
6
Utilization and Outcomes of Thrombolytic Therapy for Acute Pulmonary Embolism: A Nationwide Cohort Study.溶栓治疗急性肺栓塞的利用和结局:一项全国性队列研究。
Chest. 2020 Mar;157(3):645-653. doi: 10.1016/j.chest.2019.10.049. Epub 2019 Nov 26.
7
In-hospital outcomes of catheter-directed thrombolysis in patients with pulmonary embolism.肺栓塞患者导管定向溶栓的院内结局
Eur Heart J Acute Cardiovasc Care. 2021 May 11;10(3):258-264. doi: 10.1093/ehjacc/zuaa026.
8
A meta-analysis of outcomes of catheter-directed thrombolysis for high- and intermediate-risk pulmonary embolism.高、中危肺栓塞导管溶栓治疗结局的荟萃分析。
J Vasc Surg Venous Lymphat Disord. 2018 Jul;6(4):530-540. doi: 10.1016/j.jvsv.2018.03.010.
9
Efficacy and Safety of Anticoagulation, Catheter-Directed Thrombolysis, or Systemic Thrombolysis in Acute Pulmonary Embolism.急性肺栓塞中抗凝、导管溶栓或全身溶栓的疗效和安全性。
JACC Cardiovasc Interv. 2023 Nov 13;16(21):2644-2651. doi: 10.1016/j.jcin.2023.07.042. Epub 2023 Oct 18.
10
Outcomes of catheter-directed versus systemic thrombolysis for the treatment of pulmonary embolism: A real-world analysis of national administrative claims.导管定向溶栓与全身溶栓治疗肺栓塞的结局比较:国家行政索赔的真实世界分析。
Vasc Med. 2020 Aug;25(4):334-340. doi: 10.1177/1358863X20903371. Epub 2020 Apr 27.

引用本文的文献

1
Risk Stratification and Management of Intermediate- and High-Risk Pulmonary Embolism.中高危肺栓塞的风险分层与管理
J Clin Med. 2024 Sep 20;13(18):5583. doi: 10.3390/jcm13185583.
2
Ultrasound-Assisted Versus Standard Catheter-Directed Thrombolysis for Acute Pulmonary Embolism: Insights From National Inpatient Sample.超声辅助与标准导管定向溶栓治疗急性肺栓塞:来自全国住院患者样本的见解
J Soc Cardiovasc Angiogr Interv. 2024 Apr 5;3(5):101360. doi: 10.1016/j.jscai.2024.101360. eCollection 2024 May.
3
Clinical Outcome Using Different Catheter Interventional Treatment Modalities in High-Risk Pulmonary Artery Embolism.
高危肺动脉栓塞采用不同导管介入治疗方式的临床结局
J Cardiovasc Dev Dis. 2024 Jul 22;11(7):228. doi: 10.3390/jcdd11070228.
4
Intermediate-Risk and High-Risk Pulmonary Embolism: Recognition and Management: Cardiology Clinics: Cardiac Emergencies.中危和高危肺栓塞:识别与管理:心脏病学临床:心脏急症。
Cardiol Clin. 2024 May;42(2):215-235. doi: 10.1016/j.ccl.2024.02.008.
5
Outcomes With Hybrid Catheter-Directed Therapy Compared With Aspiration Thrombectomy for Patients With Intermediate-High Risk Pulmonary Embolism.中高危肺栓塞患者采用混合导管定向治疗与抽吸血栓切除术的疗效比较
Cardiovasc Drugs Ther. 2024 Apr 2. doi: 10.1007/s10557-024-07562-4.
6
[Catheter-Directed Thrombectomy in High-Risk Pulmonary Thromboembolism: A Case Report].[导管定向血栓切除术治疗高危肺血栓栓塞症:一例报告]
Open Respir Arch. 2023 Sep 18;5(4):100269. doi: 10.1016/j.opresp.2023.100269. eCollection 2023 Oct-Dec.
7
Initial results of investigator initiated international database on catheter directed therapy of acute pulmonary embolism.研究者发起的急性肺栓塞导管定向治疗国际数据库的初步结果。
Cardiol J. 2024;31(3):390-397. doi: 10.5603/cj.95949. Epub 2023 Sep 29.
8
Catheter-directed mechanical aspiration thrombectomy in a real-world pulmonary embolism population: a multicenter registry.在真实世界的肺栓塞人群中进行导管定向机械血栓切除术:一项多中心登记研究。
Eur Heart J Acute Cardiovasc Care. 2023 Sep 25;12(9):584-593. doi: 10.1093/ehjacc/zuad066.